Role of histamine H4 receptor in breast cancer cell proliferation

Frontiers in Bioscience - Elite

Volumn 3 E, Issue 3, 2011, Pages 1042-1060

  Medina, Vanina A ^a,b   Brenzoni, Pablo G ^a   Lamas, Diego J Martinel ^a   Massari, Noelia ^a   Mondillo, Carolina ^b,c   Nunez, Mariel A ^a   Pignataro, Omar ^b,c   Rivera, Elena S ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

Apoptosis; Cell Senescence; Human Breast Cancer; Proliferation

Indexed keywords

1 (5 CHLORO 2 INDOLYLCARBONYL) 4 METHYLPIPERAZINE; 1 [2 (AMIDINOTHIO)ETHYL]GUANIDINE; CLOBENPROPIT; CYCLIC AMP; HISTAMINE; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE H4 RECEPTOR; LIPOCORTIN 5; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; HISTAMINE RECEPTOR; HRH4 PROTEIN, HUMAN; PRIMER DNA;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL AGING; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NICK END LABELING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BREAST TUMOR; FEMALE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; FEMALE; HUMANS; IN SITU NICK-END LABELING; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80052674165     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. F. Bray, P. McCarron and D.M. Parkin: The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6, 229-239 (2004) (Pubitemid 39440251)
2. D.M. Parkin, F. Bray, J. Ferlay and P. Pisani: Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108 (2005) (Pubitemid 40372904)
3. A.M. Gonzalez-Angulo, F. Morales-Vasquez and G.N. Hortobagyi: Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 608, 1-22 (2007)
4. Z. Pós, H. Hegyesi and E.S. Rivera: Histamine and cell proliferation. Histamine: biology and medical aspects, 199-217 (2004)
5. B.C. Tilly, L.G.J. Tertoolen, R. Remorie, A. Ladoux, I. Verlaan, S.W. De Laat, et al: Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2+-mobilizing H1 receptors. J Cell Biol 110, 1211-1215 (1990)
6. E.S. Rivera, G.P. Cricco, N.I. Engel, C.P. Fitzimons, G.A. Martin and R.M. Bergoc: Histamine as an autocrine growth factor: an unusual role for a widespread mediator. Semin Cancer Biol 10, 15-23 (2000) (Pubitemid 30391952)
7. A. Falus, H. Hegyesi, E. Lazar-Molnar, Z. Pos, V. Laszlo and Z. Darvas: Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation. Trends Immunol 22, 648-652 (2001) (Pubitemid 34008594)
8. L.D. Wang, M. Hoeltzel, K. Butler, B. Hare, A. Todisco, M. Wang, et al: Activation of the human histamine H2 receptor is linked to cell proliferation and c-fos gene transcription. Am J Physiol 273, C2037-C2045 (1997) (Pubitemid 28079548)
9. C.A. Akdis and F.E.R. Simons: Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 533, 69-76 (2006) (Pubitemid 43340005)
10. M. Dy and E. Schneider: Histamine-cytokine connection in immunity and hematopoiesis. Cytokine Growth Factor Rev 15, 393-410 (2004) (Pubitemid 39140701)
11. S.J. Hill, C.R. Ganellin, H. Timmerman, J.C. Schwartz, N.P. Shankley, J.M. Young, W. Schunack, R. Levi and H.L. Haas: International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49 (3), 253-78 (1997) (Pubitemid 27414915)
12. W. Wagner, A. Ichikawa, S. Tanaka, P. Panula and W.A. Fogel: Mouse mammary epithelial histamine system. J Physiol Pharm 54, 211-223 (2003) (Pubitemid 36781475)
13. D. Kierska, W. Fogel and C. Malinski: Histamine concentration and metabolism in mouse mammary gland during estrous cycle. Inflamm Res 46 Suppl. 1, S63-S64 (1997)
14. C. Malinski, D. Kierska, W. Fogel, A. Kinnunum and P. Panula: Histamine: its metabolism and localization in mammary gland. Comp Biochem Physiol C 105, 269-273 (1993) (Pubitemid 23203998)
15. C.A. Davio, G.P. Cricco, G. Martin, C.P. Fitzsimons, R.M. Bergoc and E.S. Rivera: Effect of histamine on growth and differentiation of the rat mammary gland. Agents Actions 41, C115-C117 (1994) (Pubitemid 24199951)
16. E. Rivera, C. Davio, G. Cricco and R. Bergoc: Histamine regulation of tumour growth. Role of H1 and H2 receptors. Histamine in normal and cancer cell proliferation, 299-317 (1993)
17. C.A. Davio, G.P. Cricco, R.M. Bergoc and E.S. Rivera: H1 and H2 histamine receptors in experimental carcinomas with an atypical coupling to signal transducers. Biochem Pharmacol 50, 91-96 (1995)
18. G.P. Cricco, C.A. Davio, C.P. Fitzsimons, N. Engel, R.M. Bergoc and E.S. Rivera: Histamine as an autocrine growth factor in experimental carcinomas. Agents Actions 43, 17-20 (1994) (Pubitemid 24368177)
19. C.A. Davio, G.P. Cricco, N. Andrade, R.M. Bergoc and E.S. Rivera: H1 and H2 histamine receptors in human mammary carcinomas. Agents Actions 38, C172-C174 (1993) (Pubitemid 23145360)
20. C. Davio, A. Madlovan, C. Shayo, B. Lemos, A. Baldi and E. Rivera: Histamine receptors in neoplastic transformation. Studies in human cell lines. Inflamm Res 45 Suppl. 1, S62-S63 (1996) (Pubitemid 26097490)
21. B. Lemos, C. Davio, H. Gass, P. Gonzales, G. Cricco, G. Martín, et al: Histamine receptors in human mammary gland, different benign lesions and mammary carcinomas. Inflamm Res 44 Suppl. 1, S68-S69 (1995)
22. R. Parshad, P. Hazrah, S. Kumar, S.D. Gupta, R. Ray and S. Bal: Effect of preoperative short course famotidine on TILs and survival in breast cancer. Indian J Cancer 42, 185-190 (2005) (Pubitemid 43479199)
23. E. Bolton and J. King, D.L. Morris: H2- antagonists in the treatment of colon and breast cancer. Seminar Cancer Biol 10, 3-10 (2000) (Pubitemid 30391950)
24. J.M. Arrang, M. Garbarg and J.C. Schwartz: Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302, 832-7 (1983) (Pubitemid 13125123)
25. T.W. Lovenberg, B.I. Roland, S.J. Wilson, et al: Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 55, 1101-7 (1999) (Pubitemid 29252378)
26. G. Bongers, R.A. Bakker and R. Leurs: Molecular aspects of histamine H3 receptor. Biochem Pharmacol 73, 1195-204 (2007)
27. E. Tiligada, E. Zampeli, K. Sander and H. Stark: Histamine H3 and H4 receptors as novel drug targets. Expert Opin Investig Drugs 18, 1519-1531 (2009)
28. E. Zampeli and E. Tiligada: The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol 157, 24-33 (2009)
29. R. Leurs, P.L. Chazot, F.C. Shenton, H.D. Lim and I.J.de Esch: Molecular and biochemical pharmacology of the histamine H4 receptor. Br J Pharmacol 157, 14-23 (2009)
30. J.F. Huang and R.L. Thurmond: The new biology of histamine receptors. Curr Allergy Asthma Rep 8, 21-27 (2008) (Pubitemid 351459689)
31. R.M. van Rijn, P.L. Chazot, F.C. Shenton, K. Sansuk, R.A. Bakker and R. Leurs: Oligomerization of recombinant and endogenously expressed human histamine H(4) receptors. Mol Pharmacol 70, 604-615 (2006) (Pubitemid 44092321)
32. R.M. van Rijn, A. van Marle, P.L. Chazot, E. Langemeijer, Y. Qin, F.C. Shenton, et al: Cloning and characterization of dominant negative splice variants of the human histamine H4 receptor. Biochem J 414, 121-131 (2008)
33. V. Medina, G. Cricco, M. Nuñez, G. Martín, N. Mohamad, F. Correa-Fiz, F. Sanchez-Jimenez, R. Bergoc and E. Rivera: Histaminemediated signaling processes in human malignant mammary cells. Cancer Biol Ther 5, 1462-1471 (2006)
34. V. Medina, M. Croci, E. Crescenti, N. Mohamad, F. Sanchez-Jiménez, N. Massari, M. Nuñez, G. Cricco, G. Martin, R. Bergoc and E. Rivera: The role of histamine in human mammary carcinogenesis. H3 and H4 receptors as potential therapeutic targets for breast cancer treatment. Cancer Biol Ther 7, 27-35 (2008)
35. C. Davio, A. Mladovan, B. Lemos, F. Monczor, C. Shayo, E. Rivera, et al: H1 and H2 histamine receptors mediate the production of inositol phosphates but not cAMP in human breast epithelial cells. Inflamm Res 51, 1-7 (2002) (Pubitemid 34117366)
36. M.M. Bradford: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254 (1976)
37. C. Mondillo, Z. Patrignani, C. Reche, E. Rivera and O. Pignataro: Dual role of histamine in modulation of Leydig cell steroidogenesis via HRH1 and HRH2 receptor subtypes. Biol Reprod 73(5), 899-907 (2005) (Pubitemid 41507492)
38. B.N. Zamzami, P. Marchetti, M. Castedo, C. Zanin, J.L. Vayssiere, P.X. Petit and G. Kroemer: Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 181, 1661-72 (1995)
39. G.P. Dimri, X. Lee, G. Basile, M. Acosta, G. Scout, C. Roskelley, E. Medrano, M. Linskens, I. Rubeli, O. Pereira-Smith and M. Peacocke: A biomarker that identifies senescent human cells in culture and aging skin in vivo. Proc. Natl. Acad. Sci USA 92, 9363-9367 (1995)
40. V.A. Medina, N.A. Massari, G.P. Cricco, G.A. Martín, R.M. Bergoc and E.S. Rivera: Involvement of hydrogen peroxide in histamineinduced modulation of WM35 human malignant melanoma cell proliferation. Free Radic Biol Med 46, 1510-1515 (2009)
41. W.M. Connelly, F.C. Shenton, N. Lethbridge, R. Leurs, H.J. Waldvogel, R.L. Faull, et al: The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. Br J Pharmacol 157, 55-63 (2009)
42. I.B. Roninson: Tumor cell senescence in cancer treatment. Cancer Res 63, 2705-2715 (2003) (Pubitemid 36667137)
43. K.L. Morse, J. Behan, T.M. Laz, R.E. Jr West, S.A. Greenfeder, J.C. Anthes, et al: Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 296, 1058-1066 (2001). (Pubitemid 32187382)
44. T. Nakamura, H. Itadani, Y. Hidaka, M. Ohta and K. Tanaka: Molecular cloning and characterization of a new human histamine receptor, H4R. Biochem Biophys Res Commun 279, 615-620 (2000) (Pubitemid 32016763)
45. T. Nguyen, D.A. Shapiro, S.R. George, V. Setola, D.K. Lee, R. Cheng, et al: Discovery of a novel member of the histamine receptor family. Mol Pharmacol 59, 427-433 (2001) (Pubitemid 32179919)
46. T. Oda, N. Morikawa, Y. Saito, Y. Masuho and S. Matsumoto: Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275, 36781-36786 (2000) (Pubitemid 32002087)
47. C. Liu, X.J. Ma, X. Jiang, S.J. Wilson, C.L. Hofstra, J. Blevitt, et al: Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 59, 420-426 (2001) (Pubitemid 32179918)
48. F. Coge, S.P. Guenin, H. Rique, J.A. Boutin and J.P. Galizzi: Structure and expression of the human histamine H4-receptor gene. Biochem Biophy Res Commun 284, 301-309 (2001) (Pubitemid 32917975)
49. F. Cianchi, C. Cortesini, N. Schiavone, F. Perna, L. Magnelli, E. Fanti, et al: The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer. Clin Cancer Res 11, 6807-6815 (2005) (Pubitemid 41428735)
50. Y. Zhu, D. Michalovich, H. Wu, K.B. Tan, G.M. Dytko, I.J. Mannan, et al: Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 59, 434-441 (2001) (Pubitemid 32179920)
51. I.J. de Esch, R.L. Thurmond, A. Jongejan, R. Leurs: The histamine H4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci 26, 462-469 (2005) (Pubitemid 41207878)
52. G.P. Cricco, N.A. Mohamad, L.A. Sambuco, F. Genre, M. Croci, A.S. Gutiérrez, et al: Histamine regulates pancreatic carcinoma cell growth through H3 and H4 receptors. Inflamm Res 57 Suppl. 1, S23-S24 (2008)
53. C. Fitzsimons, N. Engel, L. Policastro, H. Durán, B. Molinari and E. Rivera: Regulation of phospholipase C activation by the number of H(2) receptors during Ca(2+)-induced differentiation of mouse keratinocytes. Biochem Pharmacol 63, 1785-96 (2002) (Pubitemid 34603443)
54. C. Davio, A. Baldi, A. Mladovan, G. Cricco, C. Fitzsimons, R. Bergoc and E. Rivera: Expression of histamine receptors in different cell lines derived from mammary gland and human breast carcinomas. Inflammation Research 44, 70 (1995)
55. F. Gbahou, L. Vincent, M. Humbert-Claude, J. Tardivel-Lacombe, C. Chabret and JM. Arrang: Compared pharmacology of human histamine H3 and H4 receptors: structureactivity relationships of histamine derivatives. Br J Pharmacol 147, 744-54 (2006)
56. D. Hanahan and R.A. Weinberg: The hallmarks of cancer. Cell 100, 57-70 (2000) (Pubitemid 30046295)
57. D.R. Camidge and D.I. Jodrell: Chemotherapy. Introduction to the cellular and molecular biology of cancer, 399-413 (2005)
58. V.A. Medina, E.S. Rivera: Histamine receptors and cancer pharmacology. Br J Pharmacol 161, 755-67 (2010)
59. K. Boer, E. Helinger, A. Helinger, P. Pocza, Z. Pos, P. Demeter, et al: Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine. Eur J Cell Biol 87, 227-236 (2008)
60. N. Matsuda, H. Teramae, M. Futatsugi, K. Takano, S. Yamamoto, K. Tomita, T. Suzuki, H. Yokoo, K. Koike and Y. Hattori: Up-regulation of histamine H4 receptors contributes to splenic apoptosis in septic mice: counteraction of the antiapoptotic action of nuclear factor-kappaB. J Pharmacol Exp Ther 332, 730-7 (2010)
61. R. Kim, M. Emi, and K. Tanabe: Role of apoptosis in cancer cell survival and therapeutic outcome. Cancer Biol. Ther 52, 1429-1424 (2006)